explore -WSS

explore

author：knowledge 2025-08-31 02:01:48 - browse：9

Dallas Mavericks owner Mark Cuban reacts during a timeout in the game against the Golden State Warriors at American Airlines Center on March 22, 2023 in Dallas, Texas. – opinion coverage from STAT — Tim Heitman/Getty Images

Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently with his direct-to-consumer venture, Cost Plus Drugs. The company sells generic prescription drugs and boasts more than 2 million members. As a family medicine specialist who has firsthand experience with American households’ dissatisfaction with the state of the nation’s prescription drug marketplace, I believe the enthusiasm for Cost Plus Drugs reveals an appetite for alternatives to the status quo in the pharmaceutical industry.

Cuban claims the reason behind the success of Cost Plus Drugs is the company’s decision to bypass pharmaceutical benefit managers — the negotiating agents insurance companies hire to negotiate big pharma’s prices down. But that might not be the case. Instead, its success appears to lie in its choice to collaborate with affordable generic drug manufacturers rather than the major pharmaceutical companies.

Last year, the Department of Health and Human Services found that between July 2021 and July 2022, major pharma companies raised the list price on more than 1,200 drugs by an average of 31 percent. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6 trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Wayne Brady comes out as pansexual: 'Free to love whomever I want'

WSS

How to use technology to prevent future drug shortages

FDA approves first blood sugar monitor without finger pricks

Emergent cuts jobs, executive role in business shake

How a key Senate committee is planning to regulate PBMs

Weekend shootings leave at least 6 dead, 20 others wounded in Chicago

Maui's cultural, historic landmarks damaged in the devastating wildfires

Wikipedia

explore

hotspot

Activists slam private health insurers over coverage restrictions

Anavex keeps shifting the goalposts in its clinical trials

In Memoriam: Notable people who died in 2023

Wegovy’s successful heart trial raises vital question about weight loss

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What to know about Virgin Galactic's 1st mission taking paying customers to space

Dobbs anniversary: the lost opportunity of abortion as health care

Statins reduce cardiovascular risk in people living with HIV

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novartis develops a rapidly manufactured CAR

Wikipedia

Naloxone nonprofit donates 200,000 doses after FDA approval

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

How to use technology to prevent future drug shortages

My chronic pain journey would have been easier knowing 5 things % STAT

Anavex keeps shifting the goalposts in its clinical trials

hotspot

hotspot

focus

focus